Humana (HUM) is a publicly traded Healthcare sector company. As of August 19, 2026, HUM trades at $378.11 with a market cap of $46.15B and a P/E ratio of 35.96. HUM moved -0.60% today. Year to date, HUM is +49.14%; over the trailing twelve months it is +33.01%. Its 52-week range spans $163.11 to $428.88. Analyst consensus is buy with an average price target of $429.86. Rallies surfaces HUM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for HUM, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $378.11 |
| Market Cap | $46.15B |
| P/E Ratio | 35.96 |
| EPS | $10.66 |
| Dividend Yield | 0.89% |
| 52-Week High | $428.88 |
| 52-Week Low | $163.11 |
| Volume | 519.85K |
| Avg Volume | 0 |
| Revenue (TTM) | $145.68B |
| Net Income | $1.29B |
| Gross Margin | 0.00% |
23 analysts cover HUM: 0 strong buy, 11 buy, 11 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $429.86.